Genus PLC (LSE:GNS) - Share price


Stock Report

Genus PLC GNS

Last Price
GBX4,930.00

Day Change
-44.00|-0.88%

As of 26/11/2021
18:02:29 GMT | GBX
Minimum 15 Minutes Delay.

Last Close4,974.00p
Day Range4,870.00 - 4,978.00
Mkt Cap3.24Bil
52-Wk Range3,896.00 - 6,310.00
Yield %0.65
ISINGB0002074580
Volume241,500
P/E68.49
P/S0.06
P/CF0.48

Share Price

Total Returns 26/11/2021

 Chg (%)  
More ...
Genus PLC-10.30 
FTSE 100 TR GBP-2.91
 
Financials
201920202021
More ...
Income Statement
Turnover488.50551.40574.30
Operating Profit30.5061.6051.00
Net Profit6.7035.7046.80
Reported EPS11.9054.0072.00
Balance Sheet
Current Assets209.00223.60231.50
Non Current Assets586.30631.60619.30
Total Assets795.50855.40851.00
Current Liabilities104.20130.20142.50
Total Liabilities316.50360.90354.40
Total Equity479.00494.50496.60
Cash Flow
Operating Cash Flow45.9073.6083.60
Net Change in Cash0.9012.006.60

Regulatory News

DateAuthor Headline
19/11/2018David Brenchley Baillie Gifford: 3 UK Stock Picks for Growth
After winning the mandate from Schroders, Milena Mileva tells us which stocks she has been buying for the Baillie Gifford UK Growth Trust this year
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
24/11/2021PurchaseMr. Stephen Wilson4,711.332,00094,227.00
24/11/2021PurchaseMr. Iain George Thomas Ferguson CBE4,495.601,00044,956.00
24/11/2021PurchaseMr. Iain George Thomas Ferguson CBE4,478.701,50067,181.00
24/11/2021PurchaseMr. Iain George Thomas Ferguson CBE4,475.202,500111,880.00

Company Profile

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. The company generates most of its revenue from its porcine exposure, followed by its bovine exposure. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Sector

Biotechnology

Index

FTSE 250 , FTSE 350 , FTSE All Share , FTSE techMARK Focus , FTSE techMARK All Share

Next Event 25/02/2022

Half-Yearly Results
Ratios
Comp
More ...
PER (E)76.81
Div Yld (E)0.54
PEG (E)0.00
ROCE8.51
Op Mrgn0.09
EPS Grwth0.01
Dividends
PreviousLatest
More ...
Record Date05/03/2119/11/21
Ex-Div04/03/2118/11/21
Paid01/04/2110/12/21
Amnt10.3021.70
Directors
More ...
Executive Director, Chief Executive OfficerMr. Stephen Wilson
Non-Executive Director, Senior Independent Director; Workforce Engagement DirectorMs. Lesley Mary Samuel Knox
Non-Executive Director, ChairmanMr. Iain George Thomas Ferguson CBE
Group General Counsel & Company SecretaryMr. Daniel William David Hartley
Non-Executive Director, Workforce Engagement DirectorMr. Lykele van der Broek
Executive Director, Chief Financial OfficerMs. Alison Henriksen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.